Patents by Inventor Xiaorong Lu

Xiaorong Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240408216
    Abstract: A protein inhibitor or degrading agent, a pharmaceutical composition comprising same and a pharmaceutical use. Provided are a compound represented by general formula (I), and a pharmaceutical composition containing same. Also disclosed are an application of the compound of the general formula as a protein inhibitor and/or a protein degrading agent and a pharmaceutical use.
    Type: Application
    Filed: June 27, 2022
    Publication date: December 12, 2024
    Inventors: Guozhong YE, Yong DU, Yuhua George ZHANG, Jinju CHEN, Shaojun CHEN, Zhi LIU, Yongfeng CHEN, Cunliang ZHAO, Yao LIU, Tao FANG, Miao YU, Xiaorong LU, Yuxia WANG, Zhaofu WANG, Qiang WU, Desheng KONG, Li ZHANG
  • Patent number: 11084790
    Abstract: The present invention provides a complex of formula (I) or a solvate thereof (wherein n is 1 to 4), a pharmaceutical composition, and use of the pharmaceutical composition in the prevention or treatment of surgical pain, intraoperative pain and postsurgical pain. The technical solution according to the present invention provides a medicament which can be produced by a simple production process and can stably release a local anesthetic in body for a long period. The medicament can be released for at least three days or more, which can prolong the analgesic effect on the postsurgical pain, can be used conveniently by the physician and the patient, and has a good treatment compliance.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: August 10, 2021
    Assignee: Fruithy Holdings Limited
    Inventors: Shanchun Zhang, Yihua Wang, Jiashi Peng, Kaisheng Cheng, Xiao Wang, Shu Gao, Hongzhang Sun, Xiaorong Lu
  • Publication number: 20210087144
    Abstract: The present invention provides a complex of formula (I) or a solvate thereof (wherein n is 1 to 4), a pharmaceutical composition, and use of the pharmaceutical composition in the prevention or treatment of surgical pain, intraoperative pain and postsurgical pain. The technical solution according to the present invention provides a medicament which can be produced by a simple production process and can stably release a local anesthetic in body for a long period. The medicament can be released for at least three days or more, which can prolong the analgesic effect on the postsurgical pain, can be used conveniently by the physician and the patient, and has a good treatment compliance.
    Type: Application
    Filed: March 26, 2018
    Publication date: March 25, 2021
    Inventors: Shanchun Zhang, Yihua Wang, Jiashi Peng, Kaisheng Cheng, Xiao Wang, Shu Gao, Hongzhang Sun, Xiaorong Lu
  • Patent number: 10568892
    Abstract: The present invention relates to the field of natural medicine and pharmaceutical chemistry, and in particular relates to a cycloartane tetracyclic triterpenoid compound (I), a preparation method thereof and the medical use thereof. The pharmacodynamic tests demonstrate that the compound of the present invention has a pharmacodynamic activity on heart and cerebral vessels and can be used to prevent or treat cardiovascular and/or cerebrovascular diseases such as arrhythmia, myocardial infarction, and coronary heart disease or the like.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: February 25, 2020
    Assignees: Hefei Cosource Pharmaceuticals Inc., Hefei Blooming Drug Safety Evaluation Co., Ltd.
    Inventors: Shanchun Zhang, Shu Gao, Xiaorong Lu, Hongzhang Sun, Yijun Bao, Bin Yang, Jiashi Peng
  • Publication number: 20190240238
    Abstract: The present invention relates to the field of natural medicine and pharmaceutical chemistry, and in particular relates to a cycloartane tetracyclic triterpenoid compound (I), a preparation method thereof and the medical use thereof. The pharmacodynamic tests demonstrate that the compound of the present invention has a pharmacodynamic activity on heart and cerebral vessels and can be used to prevent or treat cardiovascular and/or cerebrovascular diseases such as arrhythmia, myocardial infarction, and coronary heart disease or the like.
    Type: Application
    Filed: February 3, 2017
    Publication date: August 8, 2019
    Inventors: Shanchun Zhang, Shu Gao, Xiaorong Lu, Hongzhang Sun, Yijun Bao, Bin Yang, Jiashi Peng